DCM
GYRE icon

DG Capital Management’s Gyre Therapeutics GYRE Stock Holding History

DG Capital Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$22K Sell
160
-242
-60% -$36.5K 0.05% 9
2016
Q2 		$69K Sell
402
-979
-71% -$167K 0.16% 7
2016
Q1 		$261K Sell
1,381
-263
-16% -$63.4K 0.32% 15
2015
Q4 		$579K Sell
1,644
-630
-28% -$248K 0.92% 13
2015
Q3 		$1.19M Buy
2,274
+238
+12% +$363K 1.39% 14
2015
Q2 		$4.47M Buy
+2,036
New +$4.08M 3.96% 10

Other funds holding GYRE

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DG Capital Management's GYRE Position: Q3 2016 in Review

DG Capital Management reduced its Gyre Therapeutics (GYRE) stake by 60% in Q3 2016, selling an estimated $36.5K and leaving 160 shares worth $22K. The position accounts for 0.05% of the portfolio, ranked #9.

DG Capital Management first reported a position in GYRE in Q2 2015 and has held it in 6 quarters since. The position peaked at $4.47M in Q2 2015. 29 funds tracked by Wall St. Rank hold GYRE as of Q3 2016.

  • DG Capital Management held 160 shares of Gyre Therapeutics worth $22K as of Q3 2016.
  • DG Capital Management sold 242 Gyre Therapeutics shares in Q3 2016, an estimated $36.5K.
  • Gyre Therapeutics made up 0.05% of DG Capital Management's portfolio in Q3 2016, its #9 holding.
  • DG Capital Management first reported a position in Gyre Therapeutics in Q2 2015 and has held it in 6 quarters since.
  • DG Capital Management's Gyre Therapeutics position peaked at $4.47M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2016.

Based on DG Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.